Baird raised the firm’s price target on Crane NXT (CXT) to $85 from $76 and keeps an Outperform rating on the shares. The firm updated its ...

Discover Crane NXT's strong Q4 2024 earnings with 12% sales growth and strategic initiatives boosting future resilience.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Inovio Pharmaceuticals Inc. 0.00% $76.89M ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...